Therapy Linked to Lower Death Risk in Serious Tick-Borne Illness

(MedPage Today) -- Red blood cell exchange transfusion (ET) reduced the risk of in-hospital death and 30-day readmission in patients with severe cases of the tick-borne disease babesiosis, according to a target trial emulation using data from a...
Source
MedPage Today
Opens original article in a new tab



